RESPIN 1MG contains Risperidone which belongs to the group of medicines called anti-psychotic agents. It is used in the treatment of mental illness such as schizophrenia and mania. Schizophrenia is a serious mental disorder in which the person may interpret things abnormally such as seeing, hearing or feeling things that are not there, believe things that are not true or feel unusually suspicious or confused. Symptoms include delusion, hallucination, confusion, disorganized speech or thinking and bizarre behavior.
Mania is a major symptom of bipolar disorder, where the person becomes very excited, elated, agitated, enthusiastic or hyperactive. RESPIN 1MG can also be used in the short-term (up to 6 weeks) and long-term treatment of aggression in adult patients with non-responsive Alzheimer’s dementia, who harm themselves or others and in intellectually disabled children (at least 5 years of age) and adolescents with conduct disorder.
This medicine helps to alleviate the symptoms of various mood disorders by affecting the levels of chemical messengers such as dopamine and serotonin. It can be taken with or without meals. Avoid consumption of alcohol while taking this medicine. The most common side effects of taking this medicine are parkinsonism, anxiety, sleep disorders, headache, dizziness and blurred vision. Contact your doctor if any of these symptoms bothers you.
Before taking this medicine, inform your doctor if you have heart, liver, kidney or any other neurological disorders. Proper dose adjustments are required in such patients. This medicine should be used with caution in elderly patients with dementia, as there is an increased risk of stroke in such patients. This medicine is strictly not recommended for use in children under 5 years of age. Consult your doctor before taking.
Risperidone is an anti-psychotic agent which helps to alleviate the symptoms of various mood disorders by affecting the levels of chemical messengers such as dopamine and serotonin. It also stops your symptoms from coming back. It works by inhibiting the activity of dopaminergic D2 and serotonergic 5-HT2A receptors, which leads to decrease in dopaminergic and serotonergic neurotransmission, and therefore decreasing positive symptoms of schizophrenia (such as delusions and hallucinations), mania or aggression and improves your mood, thoughts or behavior.
Take RESPIN 1MG as directed by your physician. It can be taken with or without meals. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and health condition. Continue to take this medicine, as long as your doctor tells you to do so, to obtain better results.
Nausea or vomiting:
Try taking this medicine with, or just after meals. Stick to simple meals. Do not eat rich or spicy food.
Constipation:
Eat fibre rich foods like fresh fruit, vegetables and cereals. Drink plenty of water. Exercise more regularly.
Diarrhea:
Drink lots of fluids, such as water or juice, to avoid dehydration. Do not take any medicines without speaking to a doctor.
Stomach pain:
Try to rest and relax. You can eat and drink slowly or have smaller and frequent meals. Keeping a heat pad on your stomach may also help. If still pain persists, speak to your doctor.
Headache:
Rest and drink plenty of fluids. Do not drink too much alcohol.
Dizziness:
Try to rest and relax. Get enough sleep. Avoid traveling, driving or operating any tools or machines while you are feeling dizzy. If the symptom still persists, contact your doctor for advice.
RESPIN 1MG should be used with caution in pregnant women. Consult your doctor before taking this medicine.
RESPIN 1MG should be used with caution in breastfeeding women. Consult your doctor before taking this medicine.
Do not drive or operate any machines, because this medicine may cause dizziness, tiredness and vision problems.
Avoid consumption of alcohol while taking this medicine.
RESPIN 1MG should be taken with caution in patients with kidney disease. Consult your doctor for advice.
RESPIN 1MG should be taken with caution in patients with liver disease. Consult your doctor for advice.
Do not take this medicine if you are allergic to risperidone or any other ingredients in this medicine.
RESPIN 1MG should be taken with caution in patients with heart problems such as irregular heartbeat, high or low blood pressure or other cardiovascular problems. Consult your doctor for advice.
Before taking RESPIN 1MG, inform your doctor if you have following conditions:
Talk to your doctor, if you are taking,
Drug | : | Risperidone |
Pharmacological Category | : | Antipsychotic agent |
Therapeutic Indication | : | Schizophrenia, Mania, Aggression |
Dosage Forms | : | Tablet, Injection, Syrup |
Store between 15-30°C and keep out of reach of children.
Can RESPIN 1MG cause depression?
Yes. This medicine may cause depression in some patients. Contact your doctor if this symptom bothers you.
Can RESPIN 1MG cause fall?
Yes. This medicine may cause fall (suddenly falling down on the floor) in some patients. Contact your doctor if this symptom bothers you.
Can RESPIN 1MG cause high blood pressure?
Yes. This medicine may cause high blood pressure in some patients. Contact your doctor if this symptom bothers you.
Is RESPIN 1MG habit-forming?
No. This medicine is not habit-forming in nature. However, do not stop taking this medicine abruptly. Your doctor or healthcare provider will slowly reduce the dose and duration before stopping this medicine.
1. KD. Tripathi. Drugs Used in Mental Illness: Antipsychotic and Antimanic Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 441-447.
2. Jonathan M. Meyer. Pharmacotherapy of psychosis and mania. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 417-428.
3. Gerald G. Briggs and Roger K. Freeman. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 3417-3423.
4. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on June 2011] [Accessed 16th December 2020]. https://www.clinicaltrials.gov/ct2/show/study/NCT00034749
5. G Chouinard, L Kopala, A Labelle, L Beauclair, S V Johnson, K I Singh. Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group. NIH National Library of Medicine, National center for biotechnology information. Pubmed.gov. December 1998. [Accessed 16th December 2020] https://pubmed.ncbi.nlm.nih.gov/9868567/
6. BALKANPHARMA – Dupnitsa AD. Electronic Medicines Compendium (EMC); [Revised on November 2020] [Accessed 16th December 2020] https://www.medicines.org.uk/emc/files/pil.4539.pdf
7. Dexcel-Pharma Ltd. Electronic Medicines Compendium (EMC); [Revised on December 2019] [Accessed 16th December 2020] https://www.medicines.org.uk/emc/files/pil.8207.pdf
8. Janssen-Cilag SpA. Electronic Medicines Compendium (EMC); [Revised on July 2019] [Accessed 16th December 2020] https://www.medicines.org.uk/emc/files/pil.6857.pdf
9. Sun Pharmaceutical Industries Europe B.V. Electronic Medicines Compendium (EMC); [Revised on June 2018] [Accessed 16th December 2020] https://www.medicines.org.uk/emc/files/pil.4353.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.